Access to the life science market can be a headache for multinational pharma and medical device companies, let alone small-medium sized enterprises (SMEs). SMEs can face significant challenges to introduce new and innovative products into the health and social care market.
The Innovation Nexus provides a single point of access for SMEs in the life science sector to a network of specialist support within Greater Manchester.
The Innovation Nexus is a gateway to a holistic business growth support offering, focused on the specialist needs of life science SMEs, delivered through a coherent support strategy and an all-inclusive approach to helping businesses develop their growth strategies.
The aim of the Innovation Nexus is to deliver long-term health and wealth benefits to Greater Manchester through investment, innovation, education and business growth, ultimately improving the health and wellbeing of the Greater Manchester population (and beyond).
INDUSTRY PARTNERSHIP WILL BE A KEY COMPONENT OF HOW HEALTH SYSTEMS WILL IMPROVE HEALTH OUTCOMES FOR THE POPULATIONS THEY SERVE
The challenge for healthcare businesses
Companies, especially SMEs, can face significant challenges to introduce their new and innovative products into the NHS. The complexity of public procurement, patient safety and a risk averse culture across multiple organisations can be daunting. The Innovation Nexus aims to provide a single source of resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and with fewer unanticipated obstacles.
How can the Innovation Nexus help?
Help with navigating NHS procurement
Information about funding and investment
Help with setting up a trial of your innovation
Information on science parks and office locations in the GM AHSN footprint
Connections to organisations that can help you progress your innovation
Speak directly to a GM AHSN advisor with NHS expertise
Pressures in Acute Sector are target for SBRI Healthcare funding
£700K investment in innovations that target hospital efficiency
With the NHS facing unprecedented financial squeeze, improving the flow of patients, information and resources is crucial for driving up service quality and productivity, and improving patient experience. Acute trusts are experiencing significant challenges as a result of the high volume of patients leading to congestion and crisis points in many hospitals.
Today, SBRI Healthcare announced eight companies will receive funding to develop innovations that aim to improve operational efficiency in acute care through the management of patient flow. The successful technologies focus on activities that will enable more efficient progress through acute care, including diagnostics, therapy and discharge.
With awards of up to £100,000 each, the successful companies (and supporting Academic Health Science Network) are:
- Hospital Discharge Efficiency: Care Sourcer Ltd (Scotland) and IEG4 Ltd (Greater Manchester AHSN)
- Hospital In-Patient Journey: 6.P.M. Management Consultancy (UK) Ltd (Eastern AHSN) and PMD Device Solutions Ltd (Ireland)
- Hospital Resource Usage: BeamLine Diagnostics Ltd (Oxford AHSN), Highland Biosciences Ltd (Scotland), Nervecentre Software Ltd (Oxford AHSN) and Sepsis Ltd (Greater Manchester AHSN)
Shirlene Oh, Director of Commerce at Imperial College Health Partners commented:
“Media reports have stated that hospitals across the country are under significant pressure during the winter period. AHSNs are working together to find innovative solutions which address patient flow through hospital systems and acute care. The eight successful companies are developing exciting approaches to support the NHS in responding to these challenges.”
Paul Volkaerts, Chief Executive Officer at Nervecentre Software said:
“There are three pillars to maximising hospital capacity - efficient allocation of beds, understanding and managing the condition of patients, and the focus of staff upon a prioritised set of activities. We are already working with 30 Trusts and with the support of SBRI Healthcare, we can continue developing our right clinician, right place, right time concept, and translate this into effective capacity management."
SBRI Healthcare is an NHS England initiative, led by the country’s 15 Academic Health Science Networks (AHSNs), that co-develops innovative products to address unmet health needs.
The programme works with leading healthcare players to identify areas where technology can be applied to address major healthcare challenges. The eight successful projects have been selected on their potential value to the health service and on the improved outcomes delivered to patients. The companies will be supported and fully funded to demonstrate the technical feasibility of their proposed concept for a six month development phase. Those businesses demonstrating best value and greatest technical feasibility at this stage (phase 1) will progress through (phase 2) to be further supported and funded to take their technologies through to commercialisation.To find out more visit www.sbrihealthcare.co.uk
Information and guidance
Access information and guidance on a range of topics related to working with and selling to the NHS, and find clear signposts to organisations that can help you achieve your goals.